Effect of interfron in the treatment of covid

Phase 3

• Conditions: Covid pneumonia.; Coronavirus as the cause of disease; B97.2

• Registration Number: IRCT20230930059562N1
• Lead Sponsor: Imam hossein hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with Covid pneumonia who needs to hospitalised

Exclusion Criteria

Oxygen saturation percentage above 89%

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization and ambient blood oxygen saturation percentage and duration of icu needed in patients who receive interferon. Timepoint: All the time spent in hospital. Method of measurement: Investigating the effect of interferon in the treatment of corona by calculating the percentage of ambient blood oxygen and the duration of hospitalization by pulse oximetry and observing the patient's clinical condition.